Amyloidosis: open trials in Malaysia

• NCT07052903

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Trial Treatment · Phase 3 · Alnylam Pharmaceuticals

  Kajang · Kuala Lumpur

  Registry updated 2026-10-20

• NCT07223203

  TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  Trial Treatment · Phase 3 · Alnylam Pharmaceuticals

  Kuala Lumpur

  Registry updated 2026-10-08

• NCT06563895

  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company

  University Malaya Medical Centre (UMMC), Kuala Lumpur

  Registry updated 2026-08-04

All Amyloidosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error